| | | | |
CUSIP No. 68404V100 | | SCHEDULE 13G | | Page 5 of 9 Pages |
OptiNose, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Offices |
1020 Stony Hill Road, Suite 300
Yardley, Pennsylvania 19067
Item 2. | (a) Name of Person Filing |
This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the “Reporting Persons”:
(i) Avista Capital Partners II GP, LLC
(ii) Avista Capital Partners II, L.P.
(iii) Avista Capital Partners (Offshore) II, L.P.
(iv) Avista Capital Partners (Offshore) II-A, L.P.
(b) Address of Principal Business Office or, if none, Residence
All Reporting Persons:
c/o Avista Capital Partners
65 East 55th Street, 18th Floor
New York, NY 10022
(c) Citizenship
Avista Capital Partners II GP, LLC and Avista Capital Partners II, L.P.: Delaware
Avista Capital Partners (Offshore) II, L.P. and Avista Capital Partners (Offshore) II-A, L.P.: Bermuda
(d) Title of Class of Securities
Common Stock, par value $0.001 per share
(e) CUSIP Number
68404V100
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| | | | |
(a) | | ☐ | | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
| | |
(b) | | ☐ | | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
| | |
(c) | | ☐ | | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
Page 5 of 9